PostDoc grants | opnMe | Boehringer Ingelheim

Latest opportunity

Solution found

3D image analysis using AI, XR, and spatial computing

How would you propose to employ spatial computing and artificial intelligence in analyzing 3D images of tissues and organs to characterize morphological and molecular alterations induced by diseases and medications?

Nonclinical Drug Safety

Biberach

Answers: 18

Locations

Biberach

The largest research and development center of Boehringer Ingelheim is located in Biberach / Riss, Germany. This sit is also the largest site in Europe for biopharmaceutical manufacturing.

Ridgefield

Ridgefield is home to the company’s US headquarters. The site serves as a key research center for human pharmaceuticals.

Vienna

Vienna, Austria cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.

FAQs

PostDoc grants

Latest opportunity

3D image analysis using AI, XR, and spatial computing

Locations

Biberach

Ridgefield

Vienna

FAQs

How can I stay in touch with you if I do not want to apply right now, but may consider future PostDoc offers?

For how long has this program been active?

Where will the PostDoc position be located? / is it possible to carry out the research at another location?

Will other applicants be able to see my collaboration proposal?

How long does the proposal review take after my submission?

Will I be able to transfer scientific knowledge, models, or data from my current institution to you?

How is intellectual property handled as part of this PostDoc project?

What are the key success criteria for this call?

How is this call structured and how long does it take before I hear back?

Will I be able to publish my work results as part of publications?

Is there research funding available as part of this call?

What are the benefits of this new PostDoc opportunity?

How do I apply as part of this program?

What are the timelines?

What are the objectives of this new PostDoc grant initiative?